000 01710 a2200505 4500
005 20250516064956.0
264 0 _c20120411
008 201204s 0 0 eng d
022 _a1523-1747
024 7 _a10.1038/jid.2011.380
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHelmbold, Peter
245 0 0 _aRASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.
_h[electronic resource]
260 _bThe Journal of investigative dermatology
_cMar 2012
300 _a687-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBrain Neoplasms
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aCpG Islands
_xgenetics
650 0 4 _aDNA Methylation
_xdrug effects
650 0 4 _aDown-Regulation
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGene Silencing
650 0 4 _aHumans
650 0 4 _aLymphatic Metastasis
650 0 4 _aMale
650 0 4 _aMelanoma
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aNevus
_xgenetics
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aSkin Neoplasms
_xgenetics
650 0 4 _aTumor Suppressor Proteins
_xbiosynthesis
700 1 _aRichter, Antje M
700 1 _aWalesch, Sara
700 1 _aSkorokhod, Alexander
700 1 _aMarsch, Wolfgang Ch
700 1 _aEnk, Alexander
700 1 _aDammann, Reinhard H
773 0 _tThe Journal of investigative dermatology
_gvol. 132
_gno. 3 Pt 1
_gp. 687-94
856 4 0 _uhttps://doi.org/10.1038/jid.2011.380
_zAvailable from publisher's website
999 _c21339981
_d21339981